Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Hydroxycarbamid (ausschl. Dafo. FTA), ATC L01XX05 f. d. Z. 01.08.2026 - 31.07.2028 (zzgl. V.-Option 1x12 Mon)

DAK-GesundheitHamburg, GermanyEUR 1 / ~EUR 11082 days leftopen

Registrieren zum Speichern Documents (1)

Opportunity Score

Confidence: 60%

Complexity: low

1082 days

Deadline

supplies

Contract

Deep Portfolio Analysis

Company fit score
Missing certificates
Eligibility blockers
Bid / No-Bid recommendation

Create account for AI analysis

AI Analysis Summary

Strong opportunity

Non-exclusive discount agreement (Rabattvereinbarung) for Hydroxycarbamid (excluding FTA) under German social code §130a SGB V. Open-house model where any pharmaceutical company can join at any time during the contract period (01.08.2026-31.07.2028, plus 1-year extension option). Contract ends automatically when an exclusive contract is awarded. Bidders submit required documents via email; no competitive evaluation.

Strengths

Documents available

Open procedure

Low complexity

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Submission of offer letter (Angebotsschreiben)
Acceptance of contractual terms (including agreed discounts) by signing the contract
Completed Annexes 1 and 2 (Annex 2 as Excel file listing specific medicinal products)

Buyer

Name

DAK-Gesundheit

Location

Hamburg, DEU

[email protected]

Website

www.dak.de

Identifier

DE48698890

Lots (1)

#LOT-0001Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Hydroxycarbamid (ausschl. Dafo. FTA), ATC L01XX05 f. d. Z. 01.08.2026 - 31.07.2028 (zzgl. V.-Option 1x12 Mon)

Non-exclusive discount agreement for the active ingredient Hydroxycarbamid (excluding FTA form), ATC code L01XX05. Open-house model allowing any pharmaceutical company to join at any time. Contract term from 01.08.2026 to 31.07.2028, with optional 1-year extension. Automatic termination upon award of exclusive contract.

EUR 133600000DEU